Posted on July 31, 2014
Exciting news in the colon cancer world! Last week, the experimental drug MGD007 was cleared by the FDA for Phase I clinical trials in colon cancer, scheduled to start later this year. MGD007 is different from other drugs currently available because it kills cancer cells in a different way. Specifically, it binds to a protein on immune system cells (or T-cells) and directs them to kill cells that express a protein found on 95% of primary and metastatic colon cancer cells. Read more
Posted on July 21, 2014
Study: Racial Disparity in Colon Cancer
Dr. John M. Carethers, a researcher at the University of Michigan Medical School, has conducted a study that may lead to concrete conclusions as to why African Americans have lower colon cancer survival rates. The study included African American and Caucasian colon cancer patients with a goal of determining if the groups had a genetic marker called microsatellite instability (MSI). Patients with MSI tumors have higher survival rates, and it was found that 14% of Caucasians and 7% of African-Americans had MSI colon cancer. Read more
Posted on July 8, 2014
Cancer. Chemotherapy. Infusion. What image just popped into your mind? Maybe a child in a hospital bed, receiving his medicine through a port in his chest, or a young woman with a bright smile proudly showing off her newly shaved head.
We often see images like these associated with cancer treatment and chemotherapy. But what many people don’t realize is that each patient’s treatment journey is unique; as doctors and scientists become more sophisticated in the fight against cancer, there are increasingly more types of chemotherapy, drugs, dosages and treatment strategies oncologists consider when developing treatment regimens. And all of these are tailored to individuals as breakthroughs move forward at the genetic level. Read more
Posted on June 19, 2014
The Colon Cancer Alliance is committed to providing support and empowerment to those who are affected by colon cancer. This is why we’re actively addressing the patient impact of high out-of-pocket costs for medicine when it comes to the Affordable Care Act (ACA) and exchange coverage. We continue to hear the stories: due to increased costs, many patients are making decisions about treatment based on financial implication as opposed to selecting the best treatment path to address their current condition. Read more
Posted on April 5, 2014
While we often say that the colonoscopy is the “gold standard” when it comes to colon cancer screening, no test is perfect. But colonoscopy still offers the most effective screening option.
A recent study by the Huntsman Cancer Institute at the University of Utah found that about 6% of colon cancers are diagnosed within three to five years after a patient receives a clean colonoscopy. Read more